Download PDF
Indian Journal of Neurotrauma 2007; 04(02): 129-131
DOI: 10.1016/S0973-0508(07)80030-X
Case Report
Thieme Medical and Scientific Publishers Private Ltd.

Donepezil in traumatic brain injury: Report of two cases

Arun Lata Agarwal
,
Devdutta Biswas
,
Sanjay Agarwal
*   Tees, Esk & Wear Valleys NHS Trust, West Park Hospital, Darlington, England
› Author Affiliations
Subject Editor:
Further Information

Publication History

Publication Date:
05 April 2017 (online)

  PDF Download  Permissions and Reprints

Abstract

Adults with traumatic brain injury (TBI) are often severely impaired and inadequately rehabilitated due to deficits in memory and behavioral problems like apathy, irritability and depression, and it has been suggested that an acetylcholine deficit could be contributory to these deficits. Central Acetyl cholinesterase Inhibitors (CAI) are being reported to have a beneficial impact in treatment of memory deficits in adults with TBI, with Donepezil studied most extensively. The authors present two patients with TBI with long term static dysfunction of memory and behavior who responded to Donepezil in terms of attention, memory and apathy. Donepezil appears to be a valuable pharmacological option for treatment of memory and behavioral deficits in TBI.

Keywords

central acetyl cholinesterase inhibitors - Donepezil - head injury - traumatic brain injury
 

  • References

  • 1 Taverni J P, Seliger G, Lichtman SW. Donepezil mediated memory improvement in Traumatic Brain Injury during post acute rehabilitation. Brain Injury 12 1998; 77-80
    CrossrefPubMedGoogle Scholar
  • 2 Griffin SL, vanReekum R, Masanic C. A review of Cholinergic Agents in the treatment of Neurobehavioral deficits following Traumatic Brain Injury. J Neuropsychiatry Clin Neurosci 15 2003; 17-26
    CrossrefPubMedGoogle Scholar
  • 3 Tenuvio O. Central acetyl cholinesterase inhibitors in the treatment of chronic traumatic brain injury- clinical experience in 111 patients. Prog Neuropsychopharmacol Biol Psychiatry 29 2005; 61-67
    CrossrefPubMedGoogle Scholar
  • 4 Morey CE, Cilo M, Berry J, Cusick C. The effect of Aricept in persons with persistent memory disorder following Traumatic Brain Injury: a pilot study. Brain Injury 17 2003; 809-815
    CrossrefPubMedGoogle Scholar
  • 5 Zhang L, Plotkin RC, Wang G, Sandel E, Lee S. Cholinergic augmentation with Donepezil enhances recovery in short-term memory and sustained attention after Traumatic Brain Injury. Arch Phys Med Rehabil 85 2004; 1050-1055
    CrossrefPubMedGoogle Scholar
  • 6 Wheelan FJ, Sullivan Walker M, Schultz SK. Donepezil in the treatment of cognitive dysfunction associated with traumatic brain injury. Ann Clin Psychiatry 12 2000; 131-135
    CrossrefPubMedGoogle Scholar
  • 7 Masanic C, Bayley MT, vanReekum R, Simard M. Open-Label study of Donepezil in Traumatic Brain Injury. Arch Phys Med Rehabil 82 2001; 896-901
    CrossrefPubMedGoogle Scholar
  • 8 Bourgeois JA, Bahadur N, Minjares S. Donepezil for cognitive deficits following traumatic brain injury: A case report. J Neuropsychiatry Clin Neurosci 14 2002; 463-464
    CrossrefPubMedGoogle Scholar
  • 9 Kaye NS, Townsend JB, Ivins R. An open-label trial of Donepezil in the treatment of persons with mild Traumatic Brain Injury. J Neuropsychiatry Clin Neurosci 15 2003; 383-384
    CrossrefPubMedGoogle Scholar